Company Filing History:
Years Active: 2002
Title: Michael Bombara: Innovator in Cytokine Mediated Disease Treatment
Introduction
Michael Bombara is a notable inventor based in Hamden, CT (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of cytokine mediated diseases. His innovative work has the potential to impact many lives by providing new therapeutic options.
Latest Patents
Michael Bombara holds a patent for the invention titled "Inhibition of p38 kinase activity by aryl ureas." This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer. The patent also includes pharmaceutical compositions for use in such therapy. He has 1 patent to his name.
Career Highlights
Michael is currently employed at Bayer Corporation, where he continues to work on innovative solutions in the pharmaceutical industry. His role at Bayer allows him to collaborate with other talented professionals and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Gerald Ranges and William Johnston Scott. Their collective expertise enhances the innovative environment at Bayer Corporation.
Conclusion
Michael Bombara's work in the field of cytokine mediated disease treatment exemplifies the impact of innovation in healthcare. His contributions through patents and collaboration with esteemed colleagues highlight the importance of research and development in improving patient outcomes.